Levocarnitine

CHEMBL1149 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

161.2 g/mol

LogP

-0.2

Phase

4

A naturally occurring compound that plays an essential role in transporting fatty acids into mitochondria for energy production, used to treat carnitine deficiency in patients with kidney disease or those on dialysis. It supports heart and muscle energy metabolism.

Berat Molekul

161,2000 g/mol

LogP

-0,20

TPSA

60,40 Å²

Lipinski RO5

Lulus

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Rheumatoid Arthritis Osteoporosis Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Migraine Gastroesophageal Reflux Disease Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Hyperlipidemia Obesity Lymphoma Type 2 Diabetes Hypertension Breast Cancer Chronic Pain HIV/AIDS Heart Failure Atrial Fibrillation Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[N+](C)(C)C[C@H](O)CC(=O)[O-]

InChI

InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1

Molecular Formula

C7H15NO3

HBD / HBA

1 / 3

Ikatan yang Dapat Dirotasi

3

Atom Berat

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A naturally occurring compound that plays an essential role in transporting fatty acids into mitochondria for energy production, used to treat carnitine deficiency in patients with kidney disease or those on dialysis. It supports heart and muscle energy metabolism.

Yes, Levocarnitine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1149. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 10917. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Levocarnitine di PillFYI

Struktur

Data Cepat

Rumus: C7H15NO3
Sinonim: 3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.